EDGAR Filing Documents for 0001391609-17-000103

Form 8-K - Current report:

SEC Accession No. 0001391609-17-000103

Filing Date

2017-04-26

Accepted

2017-04-26 15:27:23

Documents

Period of Report

2017-02-28

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1		f8k_nulife022817.htm	8-K	21264
2	ADVISORY AGREEMENT	ex10_1advisoryagmnt.htm	EX-10.1	73142
3	STOCK PURCHASE AGREEMENT BETWEEN SEAN CLARKE AND STEVE STRASSER	ex10_2spaclarkestrasser.htm	EX-10.2	28807
4	STOCK PURCHASE AGREEMENT BETWEEN SEAN CLARKE AND KIRCHER FAMILY FOUNDATION	ex10_3spaclarkekircher.htm	EX-10.3	29954
5	STOCK PURCHASE AGREEMENT BETWEEN SEAN CLARKE AND KIRCHER FAMILY TRUST	ex10_4spaclarkekircher.htm	EX-10.4	29934
6	STOCK PURCHASE AGREEMENT BETWEEN SEAN CLARKE AND EURASIA FINANCE & DEVELOPMENT C	ex10_5spaeurasia.htm	EX-10.5	30231
7	DEBT CONVERSION AGREEMENT NULIFE AND SEAN CLARKE	ex10_6debtconversionmzhci.htm	EX-10.6	14326
	Complete submission text file	0001391609-17-000103.txt		228905

Mailing Address 1031 CALLE RECODO, SUITE B SAN CLEMENTE CA 92673

Business Address 1031 CALLE RECODO, SUITE B SAN CLEMENTE CA 92673 949-973-0684

NuLife Sciences, Inc. (Filer) CIK: 0001592603 (see all company filings)